TRIBNasdaq

TRINITY BIOTECH PLC

Healthcare·Healthcare·Bray, Ireland

TRINITY BIOTECH PLC (TRIB): 8 pipeline candidates · ~11 mo cash runway. Updated within the last hour.

7.7/10

BioSniper Score

3-factor signal · derived from public data

Cash Runway3.2

11.4 months

Financial Health10.0

D/E -3.94 · 0% dilution

Pipeline MaturityN/A

N/A

Pipeline Breadth10.0

8 candidates

Catalyst MomentumN/A

N/A

Insider SignalN/A

N/A

A transparent, data-derived signal for TRINITY BIOTECH PLCacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

$13.2M

Cash

$5.2M

Quarterly Burn

$4.2M

Runway

11.4 mo

Revenue

$61.6M

Cash Runway vs Catalysts

Tracked catalysts land within the current projected cash runway.

Cash ends ~May 2027
Today~13 mo out
Catalyst within runway

Pipeline (8 candidates)

Institutional Holdings

Source: SEC Form 13F · as of Mar 2026

Institutional holders

21

Total value held

$86K

HolderSharesValue
inspirion wealth advisors, llc25,000$14K
raymond james financial inc20,319$11K
becker capital management inc18,000$10K
renaissance technologies llc17,762$10K
geode capital management, llc16,642$9K
lpl financial llc15,036$8K
susquehanna international group, llp14,300$8K
citadel advisors llc14,200$8K
rhumbline advisers5,547$3K
jones financial companies lllp3,804$2K

Showing top 10 of 21 institutional holders of TRINITY BIOTECH PLC. Sign up for the full 13F holder list and quarter-by-quarter ownership history.

·CEO: Mr. John Gillard

Frequently asked questions

How many drug candidates are in TRINITY BIOTECH PLC's pipeline?

TRINITY BIOTECH PLC (TRIB) has 8 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.

What is TRINITY BIOTECH PLC's cash runway?

Based on its most recent reported cash balance and quarterly burn rate, TRINITY BIOTECH PLC has approximately 11.4 months of cash runway.

What is TRINITY BIOTECH PLC's market capitalization?

TRINITY BIOTECH PLC's market capitalization is approximately $13.2M.

Who is the CEO of TRINITY BIOTECH PLC?

Mr. John Gillard is the chief executive officer of TRINITY BIOTECH PLC (TRIB).

Get the full picture on TRINITY BIOTECH PLC

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.